GNS and Arvinas partner for neurodegenerative disease drug development
GNS Healthcare and Arvinas have entered into a collaboration for generating insights to help expedite neurodegenerative disease drug development.
Platform Biology News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Platform Biology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Platform Biology Today - Breaking & Trending Today
GNS Healthcare and Arvinas Enter into Neuroscience Drug Discovery Collaboration
SOMERVILLE, Mass., May 9, 2022 /PRNewswire/ -- GNS Healthcare, the leader in the use of 'Virtual Patients', Causal AI and simulation technology fo...
Source: businessinsider.com
Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology
/PRNewswire/ -- Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent and tunable medicines, has appointed Stuart Milstein,...
Source: prnewswire.com
Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology
CAMBRIDGE, Mass., Jan. 26, 2022 /PRNewswire/ -- Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent and tunab...
Source: businessinsider.com
Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology
/PRNewswire/ -- Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent and tunable medicines, has appointed Stuart Milstein,...
Source: prnewswire.com